Efficacy and Safety of Plasma Exchange with Albumin Replacement as a Therapy for Amyotrophic Lateral Sclerosis

Efficacy and Safety of Plasma Exchange with Albumin Replacement as a Therapy for Amyotrophic Lateral Sclerosis

Background: Neuroinflammation is being increasingly recognized as a key factor in the pathogenesis of amyotrophic lateral sclerosis (ALS). A therapeutic approach for ALS using plasma exchange with albumin replacement (PE-A) has been proposed to remove antibody complexes, inflammatory mediators, and...

Full description

Bibliographic Details
Main Authors: Dennis Okumu Obat, Mirjana Stevanovic, Catherine Andrews, Elsa Mondou, Zbigniew Szczepiorkowski, Miquel Barceló, Michael Ken Woodward, Nuria Ribó, Wei Liang, Elijah Stommel
Format: Article
Language:English
Published: SAGE Publishing 2022-08-01
Series:Plasmatology
Online Access:https://doi.org/10.1177/26348535221114460

Internet

https://doi.org/10.1177/26348535221114460

Similar Items